Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

Presentation TCT India 2025

ECMO rounds in ICU - De-escalation, Venting, Trouble shooting

Presenter: Venkat Goyal

July 26, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

Presentation Miami Valves 2024

Where Did The Valve Go?

Presenter: Venkatesh Alapati

February 03, 2024

Presentation STS 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presenter: Jad Malas

January 27, 2024

Presentation Controversies and Advances 2023

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Presenter: Michael Mack

November 30, 2023

Presentation Interventional Complications 2022

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Presenter: Frederick Welt

July 15, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Presentation Miami Valves 2017

Case: 81 yo Male With Severe AS

Presenter: Marek Cena

January 29, 2017

Presentation

2016 TCTMD Heart Team Survey

Presenter: 190204|Yael L. Maxwell

April 13, 2016

Presentation

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Presenter: Pil Hyung Lee

March 03, 2016

Presentation

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Presenter: William Wilson

December 22, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Presentation

Comparison of TAVR Outcome With vs Without Previous CABG

Presenter: P. Castellant

May 15, 2015

Presentation ECHO 2015

Prosthesis-Patient Mismatch: Why and How Do We Assess?

Presenter: Philippe Pibarot

April 27, 2015

Advertisement

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

ECMO rounds in ICU - De-escalation, Venting, Trouble shooting

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Short Methodology Insight - NOTION-2

Where Did The Valve Go?

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Guidelines for the Management of Valvular Heart Disease

Case: 81 yo Male With Severe AS

2016 TCTMD Heart Team Survey

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Comparison of TAVR Outcome With vs Without Previous CABG

Prosthesis-Patient Mismatch: Why and How Do We Assess?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content